CRISPR-Cas guides the future of genetic engineering
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
The diversity, modularity, and efficacy of CRISPR-Cas systems are driving a biotechnological revolution. RNA-guided Cas enzymes have been adopted as tools to manipulate the genomes of cultured cells, animals, and plants, accelerating the pace of fundamental research and enabling clinical and agricultural breakthroughs. We describe the basic mechanisms that set the CRISPR-Cas toolkit apart from other programmable gene-editing technologies, highlighting the diverse and naturally evolved systems now functionalized as biotechnologies. We discuss the rapidly evolving landscape of CRISPR-Cas applications, from gene editing to transcriptional regulation, imaging, and diagnostics. Continuing functional dissection and an expanding landscape of applications position CRISPR-Cas tools at the cutting edge of nucleic acid manipulation that is rewriting biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-Cas9 and related enzymes have been used to manipulate the genomes of cultured cells, animals and plants, vastly accelerating the pace of fundamental research and enabling breakthroughs in agriculture and synthetic biology (reviewed in refs. 6-9).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Research works printed but not linked: 3
- 47. Rousseau BA, Hou Z, Gramelspacher MJ, Zhang Y, Mol. Cell (2018), doi:10.1016/j.molcel. 2018.01.025. · doi:10.1016/j.molcel
- 63. Chen JS, Ma E, Harrington LB, Tian X, Doudna JA, bioRxiv, 226993 (2017).
- 71. Charlesworth CT et al., bioRxiv, 243345 (2018).
Cited by
Items 801–900 of 1,000
Dynamic observations of CRISPR‐Cas target recognition and cleavage heterogeneities
Zhang, Z., Jeong, H., Zu, D., Zhao, X., Senaratne, P., Filbin, J., Silber, B., Kang, S., Gladstone, A., Lau, M. S., et al. (2022) · Nanophotonics · doi:10.1515/nanoph-2022-0286 · Cited by 10
“CRISPR-Cas systems (clustered regularly interspaced short palindromic repeats) have rapidly emerged as powerful gene editing tools in life science research and disease therapeutics [1–3].”
Harnessing CRISPR-Cas for oomycete genome editing
Vink, J. N. A., Hayhurst, M., & Gerth, M. L. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.03.017 · Cited by 10
Fu, H., Shan, C., Kang, F., Yu, L., Li, Z., & Yin, Y. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05333-w · Cited by 10
“Since its discovery, CRISPR has been widely used to understand basic biological processes and has been developed as a potential game-changer for therapeutic applications [3].”
BackgroundFramework‐Hotspot Enhanced Trans Cleavage of CRISPR‐Cas12a for Clinical Samples Detection
Li, F., Li, J., Yang, W., Yang, S., Chen, C., Du, L., Mei, J., Tang, Q., Chen, X., Yao, C., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202305536 · Cited by 10
Li, H., Wang, Y., Wan, Y., Li, M., Xu, J., Wang, Q., & Wu, D. (2024) · Talanta · doi:10.1016/j.talanta.2024.125675 · Cited by 10
Recent progress on the CRISPR/Cas system in optical biosensors
Li, B., Zhai, G., Dong, Y., Wang, L., & Ma, P. (2024) · Analytical Methods · doi:10.1039/d3ay02147e · Cited by 10
Nanomaterials for intelligent CRISPR-Cas tools: improving environment sustainability
Bahl, E., Jyoti, A., Singh, A., Siddqui, A., Upadhyay, S. K., Jain, D., Shah, M. P., & Saxena, J. (2024) · Environmental Science and Pollution Research · doi:10.1007/s11356-024-32101-x · Cited by 10
“There is an inimitable demand for carriers for different nucleic acid cargos (Knott and Doudna 2018; Rasul et al. 2022; Feng et al. 2023).”
Fan, L., Qu, S., Qian, J., Shi, G., Huang, Q., Song, Y., Ji, Y., Fan, Q., & Han, X. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.152754 · Cited by 10
Mansouri, M., Mansouri, K., Taheri, Z., Alhashemi, S. H., & Dehshahri, A. (2025) · BioDrugs · doi:10.1007/s40259-025-00711-7 · Cited by 10
“These structures allow them to recognize specific cells and tissues and even function as bispecific agents capable of targeting multiple proteins simultaneously [10, 11].”
The ATF3 Transcription Factor Is a Short-Lived Substrate of the Arg/N-Degron Pathway
Vu, T. T. M., & Varshavsky, A. J. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00514 · Cited by 10
FnCas12a/crRNA assisted dumbbell-PCR detection of IsomiRs with terminal and inner sequence variants
Wang, J., Bing, T., Zhang, N., Liu, X., & Shangguan, D. (2020) · Chemical Communications · doi:10.1039/d0cc04348f · Cited by 11
Exploiting DNA Endonucleases to Advance Mechanisms of DNA Repair
Thompson, M. K., Sobol, R. W., & Prakash, A. (2021) · Biology · doi:10.3390/biology10060530 · Cited by 12
“Cas13 systems have already proven to be a useful tool in RNA interference, identifying specific RNA-associated proteins, and as a diagnostic tool [190,191].”
BackgroundDuan, M., Zhao, Y., Liu, Y., He, Y., Dai, R., Chen, J., Li, X., & Jia, F. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.168905 · Cited by 10
Liu, R., Yao, J., Zhou, S., Yang, J., Zhang, Y., Yang, X., Li, L., Zhang, Y., Zhuang, Y., Yang, Y. A., et al. (2023) · Nature Protocols · doi:10.1038/s41596-023-00920-w · Cited by 10
“In addition, CRISPR technology provides a robust and versatile approach for genome editing, live-cell imaging, high-throughput functional screening and diagnostics 15 .”
Hong, W., Huang, M., Wei, Y., & Wei, X. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1576-0 · Cited by 10
Manipulating and elucidating mitochondrial gene expression with engineered proteins
Wallis, C. P., Scott, L. H., Filipovska, A., & Rackham, O. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2019.0185 · Cited by 10
Kuhl, L., Makrantoni, V., Recknagel, S., Vaze, A. N., Marston, A. L., & Vader, G. (2020) · Genetics · doi:10.1534/genetics.120.303384 · Cited by 10
Practical Approaches for Knock-Out Gene Editing in Pigs
Ratner, L. D., Motta, G. L., Briski, O., Salamone, D., & Fernández-Martín, R. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.617850 · Cited by 10
“Genetic Modification of Animals in the New AC (After CRISPR) Era CRISPR-Cas systems were the most recently programmable endonuclease-based genetic engineering tools developed, practically monopolizing the gene editing field, since these new systems are more efficient, cheaper and simpler than the previous ones (Knott…”
MethodA chemical genetics approach to examine the functions of AAA proteins
Cupido, T., Jones, N. H., Grasso, M. J., Pisa, R., & Kapoor, T. M. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00575-9 · Cited by 12
CRISPR/Cas-mediated genome editing for improved stress tolerance in plants
Pandita, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90943-3.00001-8 · Cited by 13
Isaev, A. B., Andriianov, A., Znobishcheva, E. A., Zorin, E., Morozova, N. E., & Severinov, K. (2022) · Molecular Biology · doi:10.1134/s0026893322060073 · Cited by 11
Multiplexed functional genomic assays to decipher the noncoding genome
Cooper, Y. A., Guo, Q., & Geschwind, D. H. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac194 · Cited by 13
Expanded targeting scope and enhanced base editing efficiency in rabbit using optimized xCas9(3.7)
Liu, Z., Chen, M., Shan, H., Chen, S., Xu, Y., Song, Y., Zhang, Q., Yuan, H., Ouyang, H., Li, Z., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03110-8 · Cited by 10
Personalized precision medicine
Konieczny, L., & Roterman, I. (2019) · Bio-Algorithms and Med-Systems · doi:10.1515/bams-2019-0047 · Cited by 9
Plant virus disease management by two modern applications (dsRNA nano-clay sheet and CRISPR/Cas)
Ahsan, T., & Wu, Y. (2021) · Archives of Phytopathology and Plant Protection · doi:10.1080/03235408.2021.1910415 · Cited by 9
“Crop improvement and functional genomics are emerging trends in genome editing approaches innovations (Knott and Doudna 2018).”
BackgroundRapid and facile detection of HBV with CRISPR/Cas13a
Ding, R., Shen, Y., Yuan, M., Zheng, X. Y., Chen, S., & Duan, G. (2022) · New Journal of Chemistry · doi:10.1039/d2nj02674k · Cited by 9
CRISPR/Cas9-Mediated Genome Editing in Zebrafish
Daniel, J. G., Yu, X., Ferguson, A. C., & Shavit, J. A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2990-1_17 · Cited by 9
CRISPR-Cas immunity is repressed by the LysR-type transcriptional regulator PigU
Smith, L. M., Hampton, H. G., Yevstigneyeva, M. S., Mahler, M., Paquet, Z. S. M., & Fineran, P. C. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1165 · Cited by 11
“This diversity provides a bounty of proteins to exploit as biotechnological tools ( 10 ).”
BackgroundKnockdown of Kmt2d leads to growth impairment by activating the Akt/β-catenin signaling pathway
Shangguan, H., Huang, X., Lin, J., & Chen, R. (2024) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkad298 · Cited by 10
“Prokaryotes can precisely recognize gene sequences that re-semble phages or other invaders using the CRISPR system, and then they can employ CRISPR-associated proteins (Cas) to target these sequences for destruction (Knott and Doudna 2018).”
BackgroundGene editing in small and large animals for translational medicine: a review
Mariano, C. G., Souza, V. C. D. O., & Ambrósio, C. E. (2024) · Animal Reproduction · doi:10.1590/1984-3143-ar2023-0089 · Cited by 10
Looping forward: exploring R‐loop processing and therapeutic potential
Stratigi, K., Siametis, A., & Garinis, G. A. (2024) · FEBS Letters · doi:10.1002/1873-3468.14947 · Cited by 10
Liu, R., Xing, Y., & Shen, J. (2024) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2024.107026 · Cited by 10
Shen, P., Zhang, L., Liu, B., Li, X., Wang, C., Min, J., Huang, J., Chen, C., & Guo, R. (2024) · ACS Catalysis · doi:10.1021/acscatal.4c03278 · Cited by 9
CRISPR-Cas13-mediated RNA editing in the silkworm Bombyx mori
Tang, Y., Zhang, X., Xing, Z., Zong-Cai, D., Hao, L., Yan, Y., Tu-Jing, Z., Dong-Qin, Y., Wen-Liang, Q., Dao-Jun, C., et al. (2024) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2024.105 · Cited by 9
Walker-Gibbons, R., Xin, Z., Behjatian, A., Bennett, T. J. D., & Krishnan, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-70641-x · Cited by 9
Development of a standardized and reproducible murine femoral distraction osteogenesis model
Lin, Y., Jiang, Z., Yang, J., Wang, M., Wang, H., Zhang, X., Lu, X., Bai, S., Liang, T., Li, B., et al. (2024) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.08.001 · Cited by 9
“Recent advances in transgenic mice provide possibilities for in-depth molecular mechanisms studies [8].”
BackgroundBrant, E. J., May, D., Eid, A., & Altpeter, F. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1505844 · Cited by 9
Sitara, A., Hocq, R., Lu, A. J., & Pflügl, S. (2025) · Biotechnology for Biofuels and Bioproducts · doi:10.1186/s13068-025-02647-0 · Cited by 9
“In recent years, CRISPR/Cas-based genome editing techniques have been developed for a broad range of hosts (bacteria, archaea, fungi, yeast, mammalian cells) as they allow for efficient, precise, versatile and multiplex genome editing [20].”
Bacterial Type II Polyketide Synthases
Hu, Y., Nie, Q., Pan, H., & Tang, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14626-8 · Cited by 9
Inorganic smart nanoparticles: a new tool to deliver CRISPR systems into plant cells
Mostafa, M., Ahmed, F. K., Alghuthaymi, M. A., & Abd-Elsalam, K. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821910-2.00036-9 · Cited by 9
Meta-analysis of the effect of expression of MYB transcription factor genes on abiotic stress
Ma, Y., Shang, X., Shang, X., Shao, L., Wang, Y., Zhu, X., & Fang, W. (2021) · PeerJ · doi:10.7717/peerj.11268 · Cited by 9
SIRT7 gene knockout using CRISPR/Cas9 system enhances melanin production in the melanoma cells
Siddiqui, M. F., & Kim, M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166219 · Cited by 9
Roy, P., Moffat, K., Nair, V., & Yao, Y. (2021) · Microorganisms · doi:10.3390/microorganisms9081681 · Cited by 9
“Advances in CRISPR/Cas9 technology have revolutionized functional investigations of gene expression [16,17].”
BackgroundAlternative Splicing in Myeloid Malignancies
Gurnari, C., Pagliuca, S., & Visconte, V. (2021) · Biomedicines · doi:10.3390/biomedicines9121844 · Cited by 9
“Furthermor , the introduction of genome editing technologies, including transcription activator-like nucleases (TALENs) and CRISPR/Cas9, have been implemented to correct splicing defects [51].”
BackgroundSmall-Molecule-Mediated Split-Aptamer Assembly for Inducible CRISPR-dCas9 Transcription Activation
Liu, X., Li, B.-R., Ying, Z., Tang, L., Wang, F., & Jiang, J. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00101 · Cited by 9
Liu, H., Zhou, Y., Song, Y., Zhang, Q., Kan, Y., Tang, X., Xiao, Q., Xiang, Q., Liu, H., Luo, Y., et al. (2022) · ACS Catalysis · doi:10.1021/acscatal.2c01804 · Cited by 9
Nucleic Acid Delivery to the Vascular Endothelium
Reschke, M., Piotrowski-Daspit, A. S., Pober, J. S., & Saltzman, W. M. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00653 · Cited by 11
Chemical and Biological Approaches to Interrogate off-Target Effects of Genome Editing Tools
Lei, Z., Meng, H., Zhuang, Y., Zhu, Q., & Yi, C. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00836 · Cited by 10
Application of nucleic acid signal amplification in biosensing and bioimaging
Zhao, J., Li, X., Zhang, D., & Wang, S. (2023) · Biomedical Technology · doi:10.1016/j.bmt.2023.03.004 · Cited by 10
Anti-CRISPR with non-protein substances
Cao, M., Li, B., & Zhang, X. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.07.002 · Cited by 9
Selection of extended CRISPR RNAs with enhanced targeting and specificity
Herring‐Nicholas, A., Dimig, H., Roesing, M., & Josephs, E. A. (2024) · Communications Biology · doi:10.1038/s42003-024-05776-8 · Cited by 12
“RISPR effector Cas9 from Streptococcus pyogenes (Spy-Cas9) has emerged over the past several years as a powerful biotechnological tool that also holds tremendous potential in the treatment of genetic diseases, including several that have entered clinical trials 1,2 .”
BackgroundSite-Programmable Transposition: Shifting the Paradigm for CRISPR-Cas Systems
Chavez, M., & Qi, L. S. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.004 · Cited by 9
A new bioluminescence-based tool for modulating target proteins in live cells
Ishimoto, T., & Mori, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-54712-y · Cited by 9
Teixeira, T. L., Chiurillo, M. Á., Lander, N., Rodrigues, C. C., Onofre, T. S., Ferreira, É. R., Yonamine, C. M., Santos, J. D. G., Mortara, R. A., da Silva, C. V., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.799668 · Cited by 9
“The repair system allows the precise editing of the target gene, providing a multitude of uses (Knott and Doudna, 2018).”
BackgroundLi, Y., Liu, Y., Singh, J. K., Tangprasertchai, N. S., Trivedi, R., Fang, Y. H., & Qin, P. Z. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0100 · Cited by 9
“…set the foundation for an extensive array of Cas9-based applications in genome editing, transcription regulation, epigenetic modulation, and imaging, 5–7 and remains critical for overcoming remaining obstacles, such as the off-target effects that result in Cas9 targeting of undesired genomic sites.”
CRISPR–Cas9 can cause chromothripsis
Urnov, F. D. (2021) · Nature Genetics · doi:10.1038/s41588-021-00881-4 · Cited by 9
GEARBOCS: An Adeno Associated Virus Tool for In Vivo Gene Editing in AstrocytesPreprint
Bindu, D. S., Savage, J. T., Brose, N., Bradley, L., Dimond, K., Tan, C. X., & Eroğlu, Ç. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.17.524433 · Cited by 11
“, Clustered regularly interspaced short palindromic repeatsassociated endonuclease 9) mediated gene-editing is widely used to engineer the mammalian genome (Doudna and Charpentier, 2014; Guan et al., 2022; Hsu et al., 2014; Knott and Doudna, 2018).”
BackgroundChen, Z., Hu, J., Dai, J., Zhou, C., Hua, Y., Hua, X., & Zhao, Y. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127713 · Cited by 8
An Optimized CRISPR /Cas12a Assay to Facilitate the BRAF V600E Mutation Detection
Etemadzadeh, A., Salehipour, P., Motlagh, F. M., Khalifeh, M., Asadbeigi, A., Tabrizi, M. H., Shirkouhi, R., & Modarressi, M. H. (2024) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.25101 · Cited by 8
Öktem, M., Nguyen, T. H., Bosman, E., Fens, M. H. A. M., Caiazzo, M., Mastrobattista, E., Lei, Z., & de Jong, O. G. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113854 · Cited by 10
Non-clinical safety considerations on genome editing using the CRISPR/Cas system
Toofan, P., Singh, M., Brööks, A. G., & McLuckie, K. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101785 · Cited by 11
Uncovering Analytical Patterns for Hazardous Components in Agricultural Production Systems
Deng, S., Wu, X., Shi, Y., El‐Mesery, H. S., & Zhang, X. (2025) · Foods · doi:10.3390/foods14183261 · Cited by 9
“The CRISPR-Cas12a/crRNA complex achieves single-molecule sensitivity through sequence-specific recognition of double-stranded DNA targets [305].”
Advances in Epigenome Engineering: Mastering Technical Approaches for Better Outcomes
Khalil, A. M. (2023) · Journal of Medical Sciences and Interdisciplinary Research · doi:10.51847/ibbxxqhvqh · Cited by 8
Gan, Z., Yu, L., Liu, Y., Feng, Y., Tong, J., & Xiao, Y. (2025) · Aggregate · doi:10.1002/agt2.70180 · Cited by 8
“Since Hamilton Smith’s discovery of restriction endonucleases in 1968, numerous nucleases have been identified and widely applied in areas such as gene editing (e.g., CRISPR/Cas9) [3, 4], disease treatment, and biosensing technologies (e.g., SHERLOCK diagnostics) [5, 6].”
Recent advances in nanozyme–CRISPR/Cas biosensors
Zhang, L., He, X. J., Hu, W. W., Bai, H., Yao, Y., & Hu, W. (. (2025) · Chemical Communications · doi:10.1039/d5cc05585g · Cited by 8
Genetically encodable tagging and sensing systems for fluorescent RNA imaging
Huang, Z., Guo, X., Ma, X., Wang, F., & Jiang, J.-H. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114769 · Cited by 8
Guo, G., Li, M., Lai, J.-L., Du, Z., & Liao, Q. (2022) · Plant Science · doi:10.1016/j.plantsci.2022.111491 · Cited by 8
Functional nucleic acids as potent therapeutics against SARS-CoV-2 infection
Chen, J., Li, Y., & Liu, Z. (2023) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2023.101249 · Cited by 9
Recombinant Probiotic Preparations: Current State, Development and Application Prospects
Khablenko, A., Danylenko, S., Yalovenko, O., Дуган, О. М., Potemska, O., & Prykhodko, D. (2023) · Innovative Biosystems and Bioengineering · doi:10.20535/ibb.2022.6.3-4.268349 · Cited by 9
“Modern research and the discovery of the CRISPR-Cas system made it possible to carry out genetic modifications of various biological objects based on simpler DNA recognition, which significantly expanded the range of scientific possibilities for creating GMOs [4].”
BackgroundMao, M., Qian, Y., Zhang, W., Zhou, S., Wang, Z., Chen, X., & Yang, Y. A. (2023) · Nature Communications · doi:10.1038/s41467-023-37830-0 · Cited by 8
Terriaca, S., Monastero, R., Orlandi, A., & Balistreri, C. R. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1365711 · Cited by 8
Lee, H., Min, Y. H., Lee, D.-G., Lee, K.-H., Kim, J.-H., Lee, M., Byun, J., & Shin, Y.-B. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c01246 · Cited by 18
Shetty, A., Kwas, H., Rajhi, H., Rangareddy, H., & Fryer, J. (2024) · Cureus · doi:10.7759/cureus.71697 · Cited by 9
Dynamic sampling of a surveillance state enables DNA proofreading by Cas9
Paula, V. S. D., Dubey, A., Arthanari, H., & Sgourakis, N. G. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.10.001 · Cited by 8
One-for-all gene inactivation via PAM-independent base editing in bacteria
Li, X., Wei, Y., Wang, S., Wang, S., & Xia, P. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108113 · Cited by 10
“When a repairing template (donor DNA) is supplied, the DSB will be repaired through homologous recombination (HR), resulting in living cells with designed and clean edits in the genome (2).”
Frango, A., Chen, Q., Zhang, H., & Liu, Z. (2025) · Food Analytical Methods · doi:10.1007/s12161-024-02754-y · Cited by 8
“The development and implementation of genome editing technologies have revolutionized the field of genetic engineering, particularly with the advent of CRISPR/Cas9 (Knott and Doudna 2018; Zhang et al. 2020).”
Gong, L., Liu, X., Wu, J., & He, M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01292-x · Cited by 11
Distribution of CRISPR-Cas systems in the Burkholderiaceae family and its biological implications
Kerber-Díaz, J.-C., Leos-Ramírez, M. A., Flores-Cerón, A., Mendoza, A. P., Santos, P. E. L., & Ibarra, J. A. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-03312-y · Cited by 8
“2009; Marraffini 2015; Knott and Doudna 2018Makarova et al.”
BackgroundPaulini, K., Lypaczewski, P., Zhang, W., Perera, D. J., Ndao, M., & Matlashewski, G. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7110384 · Cited by 8
“New genome editing technologies, such as CRISPR-Cas9, have greatly improved our ability to study proteins of interest by specifically deleting or altering the genes encoding them [20].”
BackgroundFull-Length Model of SaCas9-sgRNA-DNA Complex in Cleavage State
Du, W., Zhu, H., Qian, J., Xue, D., Zheng, S., & Huang, Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021204 · Cited by 8
Teng, Y., Wang, J., Jiang, T., Zou, Y., & Yan, Y. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00366 · Cited by 8
Discovery of the widespread site-specific single-stranded nuclease family Ssn
Chenal, M., Rivera-Millot, A., Harrison, L. B., Khairalla, A. S., Nieves, C., Bernet, È., Esmaili, M., Belkhir, M., Perreault, J., & Veyrier, F. J. (2025) · Nature Communications · doi:10.1038/s41467-025-57514-1 · Cited by 9
“The past decade has also seen the development of CRISPR-associated proteins (Cas) into site-speci fi c nucleasescapableofcleavingvirtuallyanyDNAsequence,unleashinga biotechnological revolution 2 .”
The STING-STAT6 pathway drives Cas9-induced host response in human monocytes
Kang, R., Zhu, S., Zeh, H. J., & Tang, D. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.080 · Cited by 8
“Over the past few years, the CRISPR (clustered regularly interspaced short palindromic repeats)-Cas9 (CRISPR-associated protein 9) system has become the most popular gene editing tool in biomedical science [1, 2].”
BackgroundYang, Y., & Huang, Y. (2019) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12061 · Cited by 8
Молекулярно-биологические аспекты депрессивных состояний: современный взгляд на проблему
Ushakova, V. M., Морозова, А. Ю., Reznik, A. M., Kostyuk, G. P., & Chekhonin, V. P. (2020) · Molecular Biology · doi:10.31857/s0026898420050110 · Cited by 12
Environmental DNA for conservation
Piaggio, A. J. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780198850243.003.0008 · Cited by 11
Role of RS-1 derivatives in homology-directed repair at the human genome ATG5 locus
Jeon, I.-S., Shin, J., Kim, S. R., Park, K. S., Yoo, H. J., Lee, K. Y., Lee, H., & Choi, J.-K. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01226-1 · Cited by 8
“transcription activator-like effector-based nuclease (TALEN) systems are available to create site-specific double-strand breaks (DSBs) at desired locations in the genome (Cho et al. 2013; Hsu et al. 2014; Knott and Doudna 2018).”
BackgroundMeng, Q., Stoyko, D., Andrews, C. M., Κωνσταντινίδου, Π., Genzor, P., Timothy, O., Elchert, A. R., Benner, L., Sobti, S., Katz, E. Y., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac448 · Cited by 8
Structural basis of Cas12a R-loop propagation on pathway to DNA cleavagePreprint
Strohkendl, I., Moy, C., Nguyen, A.-H., Russell, R., & Taylor, D. W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.13.532460 · Cited by 8
The path to biotechnological singularity: Current breakthroughs and outlook
Wen, Z., Yang, D., Yang, Y., Hu, J., Parviainen, A., Chen, X., Li, Q., VanDeusen, E. A., Ma, J., & Tay, F. R. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108667 · Cited by 8
Wang, Q., Sheng, M., Zheng, Y., Zhang, B., Jin, Z., Zhang, T., Li, Z., Huang, J., & Yang, X. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c07500 · Cited by 7
Applied aspects of gene function for the conservation of fishes
Jeffries, K. M., Jeffrey, J. D., & Holland, E. B. (2022) · Fish physiology · doi:10.1016/bs.fp.2022.04.008 · Cited by 9
Cao, H., Mao, K., Zhang, H., Wu, Q., Ju, H., & Feng, X. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.168536 · Cited by 7
Siraj, N., Dilfy, S. H., & Abduljaleel, R. H. (2023) · Trends in Pharmaceutical Biotechnology · doi:10.57238/tpb.2023.144271.1002 · Cited by 10
“Subsequently, a complex is formed between the Cas protein, other RNA molecules, and the crRNA, which ultimately leads to the cleavage of DNA (Fig.1) [4].”
BackgroundRecent Advances in CRISPR/Cas9-Mediated Genome Editing in Leishmania Strains
Ghavidel, A. A., Aghamiri, S., Raee, P., Mohammadi‐Yeganeh, S., Noori, E., Bandehpour, M., Kazemi, B., & Jajarmi, V. (2023) · Acta Parasitologica · doi:10.1007/s11686-023-00756-0 · Cited by 7
“The Cas9 is an RNA-guided endonuclease used for site-specific genome editing in a variety of organisms [22, 23], including Leishmania [24].”
Prokhorova, D. V., Kupryushkin, M. S., Zhukov, S. A., Zharkov, T. D., Dovydenko, I. S., Yakovleva, K. I., Pereverzev, I. M., Matveeva, A. M., Pyshnyi, D. V., & Stepanov, G. A. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00147 · Cited by 7
Yang, X., Shi, X., Lv, C., Liu, W., Zhang, F., & Liu, B. (2025) · ACS Omega · doi:10.1021/acsomega.5c00660 · Cited by 7
Kumar, N. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01972-x · Cited by 8
The SoyaGen Project: Putting Genomics to Work for Soybean Breeders
Belzile, F. J., Jean, M., Torkamaneh, D., Tardivel, A., Lemay, M., Boudhrioua, C., Arsenault‐Labrecque, G., Dussault‐Benoit, C., Lebreton, A., de Ronne, M., et al. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.887553 · Cited by 7
“In addition to already known E genes, a novel association was detected on chromosome13 near a trio of orthologs of the Arabidopsis HAP5 gene, one shown to promote flowering under long days (Cai et al., 2007; Kumimoto et al., 2008).”
BackgroundRao, Y., Yang, J., Wang, J., Yang, X., Zhang, M., Zhan, Y., Ma, X., Cai, D., Wang, Z., & Chen, S. (2022) · Bioresources and Bioprocessing · doi:10.1186/s40643-022-00597-1 · Cited by 7
Metadata
- Authors
- Knott, G. J., & Doudna, J. A.
- Affiliations
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Doudna, Jennifer A.
- Venue
- Science
- Published
- 2018-08-31
- Volume
- 361
- Issue
- 6405
- Pages
- 866-869
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6455913
- OpenAlex
- W2888908334
- Cited by
- 1,410
- References
- 76
- Citations by year
- 2026: 92 · 2025: 155 · 2024: 169 · 2023: 177 · 2022: 214 · 2021: 223 · 2020: 205 · 2019: 149 · 2018: 23
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR-Cas, genome editing, transcriptional regulation, CRISPR-Cas diagnostics, agricultural biotechnology
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, RNA, Guide, CRISPR-Cas Systems, Animals, Bacterial Proteins, DNA, Endonucleases, Genetic Engineering, Humans, Plants, RNA, Transcription, Genetic, Molecular Imaging, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.